Decentralized Clinical Trials
In October 2019, ACRO established the Decentralized Clinical Trials Working Party to examine the barriers to adoption of DCTs and create quality-based principles and tools to facilitate implementation of decentralized clinical trials.
Thought Leadership on DCTs
ACRO’s white paper provides an overview of key considerations in the decentralization of clincal trials. ACRO’s DCT Toolkit includes five resources: (1) a detailed QbD Manual for DCTs; (2) an accessible, quick-reference QbD Manual; (3) a Risk Assessment Considerations template; (4) DCT Data Flow Maps; and (5) a Change Management Question-and-Answer resource. ACRO members are dedicated to helping bring quality-based principles, risk-assessment tools, and patient-centricity to the decentralized trials process.
Initiatives Resources
Filter Results:
Report
ACRO Op Ed in Pharma Letter: Realizing the promise of decentralized trials
Decentralized Trials